Get the Stockscreener App
0.5829
5.82%
-0.036
Cosmos Health Inc stock is traded at $0.5829, with a volume of 160.46K.
It is down -5.82% in the last 24 hours and down -19.04% over the past month.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
See More
Previous Close:
$0.6189
Open:
$0.64
24h Volume:
160.46K
Relative Volume:
0.66
Market Cap:
$13.56M
Revenue:
$49.59M
Net Income/Loss:
$-15.61M
P/E Ratio:
-0.1018
EPS:
-5.7281
Net Cash Flow:
$-32.55M
1W Performance:
-19.27%
1M Performance:
-19.04%
6M Performance:
-18.93%
1Y Performance:
-54.46%
1-Day Range:
$0.5829
$0.6477
1-Week Range:
$0.5829
$0.73
52-Week Range:
$0.4677
$1.65
Cosmos Health Inc Stock (COSM) Company Profile
Name
Cosmos Health Inc
Sector
Industry
Phone
312-536-3102
Address
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Compare COSM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COSM
Cosmos Health Inc
|
0.5829 | 13.56M | 49.59M | -15.61M | -32.55M | -3.9981 |
|
MCK
Mckesson Corporation
|
579.74 | 73.59B | 330.19B | 2.54B | 4.31B | 19.31 |
|
COR
Cencora Inc
|
227.69 | 44.01B | 293.96B | 1.51B | 3.00B | 7.51 |
|
CAH
Cardinal Health Inc
|
118.28 | 28.63B | 224.34B | 1.26B | 1.08B | 5.14 |
|
HSIC
Henry Schein Inc
|
69.82 | 8.71B | 12.50B | 314.00M | 421.00M | 2.44 |
|
PDCO
Patterson Companies Inc
|
30.86 | 2.72B | 6.53B | 168.41M | -885.03M | 1.83 |
Cosmos Health Inc Stock (COSM) Latest News
Cosmos Health (NASDAQ:COSM) Stock Price Down 5.7% – Here’s Why - Defense World
Taglich Brothers Releases Updated Coverage on Cosmos Health: Projects Positive EPS for 2025 and Sets $3 Price Target, Nearly 300% Above Current Share Price - AccessWire
Cosmos Health Projects 25% Revenue Growth to $68.4M by 2025, Taglich Maintains Buy Rating | COSM Stock News - StockTitan
Cosmos Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Cosmos Health shareholders approve key proposals - Investing.com
Cosmos Health Picks Bitcoin for Its Treasury - Altcoin Buzz
Cosmos Health to accumulate BTC and Ethereum and accept crypto payments - TU News
Cosmos Health adds Bitcoin and Ethereum to treasury reserves - MSN
Planning Ahead: Cosmos Health Looks to Add Bitcoin and Ethereum to Its Treasury - Bitcoin.com News
More companies name BTC a treasury reserve asset - Blockworks
Another Publicly Traded Company Adds Bitcoin to Its Balance Sheet - Decrypt
Cosmos Health integrates bitcoin, ethereum as treasury reserve assets - TipRanks
Cosmos Health Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St
Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets - AccessWire
Cosmos Health reports steady Q3 financials, cuts costs - Investing.com India
Cosmos Health Reports Q3 2024 Results: Resilient Revenue and Gross Profit Amid 18.6% Expense Reduction; Stockholders' Equity Up 8.8% to $35M - AccessWire
Cosmos Health Reports Q3 2024 Results: Resilient Revenue and Gro - WICZ
ARMISTICE CAPITAL, LLC Acquires New Stake in Cosmos Health Inc - GuruFocus.com
Cosmos Health Inc. (COSM) Quarterly 10-Q Report - Quartzy
Cosmos Health Q3: Amazon UK Sales Surge 160% Despite Revenue Dip; Operating Costs Down 19% | COSM Stock News - StockTitan
Cosmos Health reports revenue growth and strategic expansions - Investing.com
Cosmos Health anticipates ‘substantial value creation’ by 2027 - TipRanks
Cosmos Health (COSM) Reports 18% Q1 Growth, Projects $155M Revenue by 2027 | COSM Stock News - StockTitan
Cosmos Health reports revenue growth and strategic expansions By Investing.com - Investing.com UK
Cosmos Health Issues Letter to Shareholders - AccessWire
EXCLUSIVE: Virax Biolabs Inks Distribution Pact For Mpox Diagnostic Kits In Europe And Middle East - AOL
Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21% - Big News Network
CosmoFarm reports 8.62% revenue increase in 2024 By Investing.com - Investing.com Canada
CosmoFarm reports 8.62% revenue increase in 2024 - Investing.com India
Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with - PharmiWeb.com
Cosmos Health’s Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21% - StockTitan
Cointreau Is Shaking Up Holiday Entertaining with Limited-Edition Cointreau, Cosmos + Caviar Kit - Yahoo Finance
Cosmos Health (NASDAQ:COSM) versus Sinopharm Group (OTCMKTS:SHTDF) Financial Contrast - Defense World
Head to Head Survey: Cosmos Health (NASDAQ:COSM) and Sinopharm Group (OTCMKTS:SHTDY) - Defense World
Cosmos Healthcare Introduces Neuromap® and QPAN Model: AI-Driven Personalized Care for Autism & Neurological - EIN News
Virax Biolabs Group Limited Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland - Marketscreener.com
Contrasting Sinopharm Group (OTCMKTS:SHTDF) & Cosmos Health (NASDAQ:COSM) - Defense World
Analyzing McKesson Europe (OTCMKTS:CAKFY) and Cosmos Health (NASDAQ:COSM) - Defense World
Pre-market Movers: ALZN, VRAX, APDN, LQDA... - RTTNews
An Epic Dystopia - The American Prospect
Cosmos Health (NASDAQ:COSM) vs. ScripsAmerica (OTCMKTS:SCRCQ) Critical Contrast - Defense World
Taking the lead: Cosmos Health Inc (COSM) - SETE News
Evaluating COSM’s financial ratios for a profitable investment - US Post News
Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands - AccessWire
Company’s Banking Shares: Up -50.73% from 52-Week Low, But Can the Momentum Hold? - The InvestChronicle
Investor’s Delight: Cosmos Health Inc (COSM) Closes Weak at 1.01, Down -8.18 - The Dwinnex
Cosmos Health Inc Stock (COSM) Financials Data
Revenue
Net Income
Cash Flow
EPS
16.96%
0.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):